Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Employment Offer Letter
- 10.2 Severance and Change In Control Agreement
- 31.1 Certification Pursuant to Rule 13A-14(A) of Joseph K. Belanoff, M.D.
- 31.2 Certification Pursuant to Rule 13A-14(A) of Caroline M. Loewy
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350 of Joseph K. Belanoff, M.D.
- 32.2 Certification Pursuant to 18 U.s.c. Section 1350 of Caroline M. Loewy
CORT similar filings
Filing view
External links
Exhibit 32.2
Corcept Therapeutics Incorporated
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Corcept Therapeutics Incorporated (the “Company”) on Form 10-Q for the quarter ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Caroline M. Loewy, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Caroline M. Loewy |
Caroline M. Loewy |
Chief Financial Officer |
November 12, 2010